| For: | Zhang L, Bai CZ, Shan JY, Xue HL, Zheng SM, Chen YL, Tang SH. Flotillin-1 promotes the progression of hepatocellular carcinoma by activating TFE3-mediated Golgi stress response via inhibition of mTORC1/2. World J Gastroenterol 2025; 31(29): 106895 [PMID: 40809929 DOI: 10.3748/wjg.v31.i29.106895] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i29/106895.htm |
| Number | Citing Articles |
| 1 |
Chiara Mazziotta, John Charles Rotondo. Unraveling the role of flotillin-1 in driving hepatocellular carcinoma progression through transcription factor E3-mediated Golgi stress response. World Journal of Gastroenterology 2025; 31(38): 112489 doi: 10.3748/wjg.v31.i38.112489
|
| 2 |
Xiangyun Li, Shihan Du, Yimeng Wang, Yan Huang, Ye Zhang, Chengyu Li, Zhaoguo Liu, Shuan Dong, Ya Wu, Shasha Liu, Jia Shi, Yuan Zhang, Jianbo Yu. HO-1 alleviates lipopolysaccharide-induced acute lung injury in mice by downregulating TFE3 expression and nuclear translocation and suppressing Golgi stress response. International Immunopharmacology 2026; 186 doi: 10.1016/j.intimp.2026.117103
|
| 3 |
Jing Sun, Jian Zheng, Weiyi Zhu, Yang Bi, Yun He. All‐Trans Retinoic Acid Suppresses Hepatocellular Carcinoma Progression via the CSTB/CYTB Axis. Journal of Cellular and Molecular Medicine 2026; 30(2) doi: 10.1111/jcmm.71012
|
| 4 |
Yakun Liu, Zhi Yang, Zhencai Xing, Rongrong Zhao, Yixuan Zhou, Xue Yang, Jicheng Zhu, Shuo Chen, Yuhang Zhang, Mengxue Xu, Xiang Kong, Minqiong Sun, Zhenya Tan, Hong Zheng. Metabolic Reprogramming and Exosome Remodeling in an Ndufs4‐Deficient Model of Leigh Syndrome. iNew Medicine 2026; 2(2) doi: 10.1002/inm3.70055
|